Literature DB >> 29069563

Abiraterone in Metastatic Prostate Cancer.

Nicholas D James1, Melissa R Spears2, Matthew R Sydes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29069563     DOI： 10.1056/NEJMc1711029

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Conceptual review of key themes in treating prostate cancer in older adults.

Authors:  Ramy Sedhom; Arjun Gupta
Journal:  J Geriatr Oncol       Date:  2019-11-05       Impact factor: 3.599

Review 2.  Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer.

Authors:  Marlon Perera; Matthew J Roberts; Laurence Klotz; Celestia S Higano; Nathan Papa; Shomik Sengupta; Damien Bolton; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2020-06-30       Impact factor: 14.432

Review 3.  Recent Advances in Prostate Cancer Treatment and Drug Discovery.

Authors:  Ekaterina Nevedomskaya; Simon J Baumgart; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

4.  Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.

Authors:  Jennifer L Beebe-Dimmer; Julie J Ruterbusch; Kathleen A Cooney; Adam Bolton; Kendra Schwartz; Ann G Schwartz; Elisabeth Heath
Journal:  Cancer Med       Date:  2019-05-15       Impact factor: 4.452

5.  Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways.

Authors:  Hongwei Wang; Shikui Song; Fei Peng; Fei Yang; Tian Chen; Xin Li; Xiyao Cheng; Yijun He; Yongqi Huang; Zhengding Su
Journal:  Microb Cell Fact       Date:  2020-10-02       Impact factor: 5.328

6.  Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer.

Authors:  Malgorzata K Nowakowska; Xiudong Lei; Mackenzie R Wehner; Paul G Corn; Sharon H Giordano; Kevin T Nead
Journal:  JAMA Netw Open       Date:  2021-12-01

7.  Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.

Authors:  Stéphane Supiot; Loic Campion; Pascal Pommier; Mélanie Dore; Clément Palpacuer; Séverine Racadot; Emmanuel Rio; Gérard A Milano; Céline Mahier-Ait Oukhatar; Christian Carrie
Journal:  Oncotarget       Date:  2018-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.